Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grups

Publicacions

  • Moreno-Moreno, E; Caniego-Casas, T; Carretero-Barrio, I; Cortés, A; Muriel, A; Domínguez-Rullán, JA; Martín-Gromaz, C; Moreno-Bueno, G; Matías-Guiu, X; Palacios, J; Pérez-Mies, B

    Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 48 1580-1587. .

    [doi:10.1097/PAS.0000000000002308]

  • Matias-Guiu, X; Lax, S; Raspollini, MR; Palacios, J; Zheng, WX; Liu, CR; de Brot, L; Lordello, L; Hardisson, D; Gaffney, D; Mutch, D; Scambia, G; Creutzberg, CL; Fotopoulou, C; Berek, JS; Concin, N

    FIGO 2023 staging for endometrial cancer, when, if it is not now?

    EUROPEAN JOURNAL OF CANCER 213 -. .

    [doi:10.1016/j.ejca.2024.115115]

  • Navarro-Masip, E; Petit, NM; Salinas-Roca, B; Herrerías, F; VILARDELL, F; de la Fuente, MC; Pallares, J; Santamaría, M; Zorzano-Martínez, M; Sánchez, E; Matías-Guiu, X; López-Cano, C; Soler, AG; León-Mengíbar, J; Bueno, M; Lecube, A

    Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver®) Diagnoses

    Obesity Facts 17 473-482. .

    [doi:10.1159/000538765]

  • von der Heyde, S; Raman, N; Gabelia, N; Matias-Guiu, X; Yoshino, T; Tsukada, Y; Melino, G; Marshall, JL; Wellstein, A; Juhl, H; Landgrebe, J

    Tumor specimen cold ischemia time impacts molecular cancer drug target discovery

    CELL DEATH & DISEASE 15 -. .

    [doi:10.1038/s41419-024-07090-x]

  • Casas-Arozamena, C; Vilar, A; Cueva, J; Arias, E; Sampayo, V; Diaz, E; Oltra, SS; Moiola, CP; Cabrera, S; Cortegoso, A; Curiel, T; Abalo, A; Serrano, MP; Domingo, S; Padilla-Iserte, P; de la Cruz, MA; Hernández, A; García-Pineda, V; Ruiz-Bañobre, J; López, R; Matias-Guiu, X; Colás, E; Gil-Moreno, A; Abal, M; Moreno-Bueno, G; Muinelo-Romay, L

    Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 43 -. .

    [doi:10.1186/s13046-024-03158-w]

  • Altés, G; Olomí, A; Perramon-Guell, A; Hernandez, S; CASANOVAS, A; Perez, A; Diaz-Tocados, JM; Valdivielso, JM; Megino, C; Navaridas, R; Matias-Guiu, X; Klein, OD; Egea, J; Dolcet, X; Yeramian, A; Encinas, M

    Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice

    SCIENTIFIC REPORTS 14 -. .

    [doi:10.1038/s41598-024-70529-w]

  • Mutch, D; Gaffney, D; Matias-Guiu, X; Fotopoulou, C; Concin, N; Berek, JS

    Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification

    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS 165 1304-1305. .

    [doi:10.1002/ijgo.15478]

  • León-Mengibar, J; Sánchez, E; Herrerías, F; de la Fuente, MC; Santamaría, M; Valdivielso, JM; Bermúdez-López, M; Castro, E; Pallarés, J; Matias-Guiu, X; VILARDELL, F; Caixàs, A; Bueno, M; Marti, R; Lecube, A

    Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology 15 1366015-1366015. .

    [doi:10.3389/fendo.2024.1366015]

  • Gaffney, D; Matias-Guiu, X; Mutch, D; Scambia, G; Creutzberg, C; Fotopoulou, C; Berek, JS; Concin, N

    2023 FIGO staging system for endometrial cancer: The evolution of the revolution

    GYNECOLOGIC ONCOLOGY 184 245-253. .

    [doi:10.1016/j.ygyno.2024.02.002]

  • Matias-Guiu, X; Hoefler, G

    Molecular pathology as basis for timely cancer diagnosis and therapy

    VIRCHOWS ARCHIV 484 151-154. .

    [doi:10.1007/s00428-024-03767-y]

  • Ledermann, JA; Matias-Guiu, X; Amant, F; Concin, N; Davidson, B; Fotopoulou, C; González-Martin, A; Gourley, C; Leary, A; Lorusso, D; Banerjee, S; Chiva, L; Cibula, D; Colombo, N; Croce, S; Eriksson, AG; Falandry, C; Fischerova, D; Harter, P; Joly, F; Lazaro, C; Lok, C; Mahner, S; Marmé, F; Marth, C; McCluggage, WG; McNeish, IA; Morice, P; Nicum, S; Oaknin, A; Pérez-Fidalgo, JA; Pignata, S; Ramirez, PT; Ray-Coquard, I; Romero, I; Scambia, G; Sehouli, J; Shapira-Frommer, R; Sundar, S; Tan, DSP; Taskiran, C; van Driel, WJ; Vergote, I; Planchamp, F; Sessa, C; Fagotti, A

    ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    ANNALS OF ONCOLOGY 35 248-266. .

    [doi:10.1016/j.annonc.2023.11.015]

  • Santoro, A; Bragantini, E; Castiglione, F; Ganesan, R; Matias-Guiu, X; Frattini, M; Gallotta, V; Garcia, P; Pattni, Y; Tsiampali-Laprell, J; Bisaro, B; Barbareschi, M; Zannoni, GF

    Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs

    Pathologica 116 32-45. .

    [doi:10.32074/1591-951X-926]

Projectes

  • Carcinoma de endometrio participación de las vias de señalización implicadas en la apoptosis y su relación con la hipoxia
  • ALTERACIONS MOLECULARS EN EL DESENVOLUPAMENT I PROGRESSIO DEL CARCINOMA D'ENDOMETRI. RELEVANCIA CLINICA DE LES ALTERACIONS EN RECEPTORS DE MORT.